FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q33163524> ?p ?o ?g. }

• Q33163524 description "2013 nî lūn-bûn" @default.
• Q33163524 description "2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած" @default.
• Q33163524 description "2013 թվականի նոյեմբերին հրատարակված գիտական հոդված" @default.
• Q33163524 description "2013年の論文" @default.
• Q33163524 description "2013年論文" @default.
• Q33163524 description "2013年論文" @default.
• Q33163524 description "2013年論文" @default.
• Q33163524 description "2013年論文" @default.
• Q33163524 description "2013年論文" @default.
• Q33163524 description "2013年论文" @default.
• Q33163524 description "2013年论文" @default.
• Q33163524 description "2013年论文" @default.
• Q33163524 description "2013年论文" @default.
• Q33163524 description "2013年论文" @default.
• Q33163524 description "2013年论文" @default.
• Q33163524 description "2013년 논문" @default.
• Q33163524 description "article científic" @default.
• Q33163524 description "article scientific" @default.
• Q33163524 description "article scientifique (publié 2013)" @default.
• Q33163524 description "articol științific" @default.
• Q33163524 description "articolo scientifico" @default.
• Q33163524 description "artigo científico (publicado na 2013)" @default.
• Q33163524 description "artigo científico (publicado na 2013)" @default.
• Q33163524 description "artigo científico" @default.
• Q33163524 description "artikull shkencor" @default.
• Q33163524 description "artikulong pang-agham" @default.
• Q33163524 description "artykuł naukowy" @default.
• Q33163524 description "artículo científico publicado en 2013" @default.
• Q33163524 description "artículu científicu espublizáu en 2013" @default.
• Q33163524 description "bilimsel makale" @default.
• Q33163524 description "bài báo khoa học" @default.
• Q33163524 description "mokslinis straipsnis" @default.
• Q33163524 description "naučni članak" @default.
• Q33163524 description "scienca artikolo" @default.
• Q33163524 description "scientific article" @default.
• Q33163524 description "teaduslik artikkel" @default.
• Q33163524 description "tieteellinen artikkeli" @default.
• Q33163524 description "tudományos cikk" @default.
• Q33163524 description "vedecký článok" @default.
• Q33163524 description "vetenskaplig artikel" @default.
• Q33163524 description "videnskabelig artikel (udgivet 2013)" @default.
• Q33163524 description "vitenskapelig artikkel" @default.
• Q33163524 description "vitskapeleg artikkel" @default.
• Q33163524 description "vědecký článek" @default.
• Q33163524 description "wetenschappelijk artikel" @default.
• Q33163524 description "wissenschaftlicher Artikel" @default.
• Q33163524 description "επιστημονικό άρθρο" @default.
• Q33163524 description "мақолаи илмӣ" @default.
• Q33163524 description "мақолаи илмӣ" @default.
• Q33163524 description "наукова стаття, опублікована в листопаді 2013" @default.
• Q33163524 description "научна статия" @default.
• Q33163524 description "научная статья" @default.
• Q33163524 description "научни чланак" @default.
• Q33163524 description "научни чланак" @default.
• Q33163524 description "מאמר מדעי" @default.
• Q33163524 description "سائنسی مضمون" @default.
• Q33163524 description "مقالة علمية" @default.
• Q33163524 description "مقالهٔ علمی" @default.
• Q33163524 description "২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q33163524 description "บทความทางวิทยาศาสตร์" @default.
• Q33163524 description "სამეცნიერო სტატია" @default.
• Q33163524 name "Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study" @default.
• Q33163524 name "Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study" @default.
• Q33163524 type Item @default.
• Q33163524 label "Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study" @default.
• Q33163524 label "Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study" @default.
• Q33163524 prefLabel "Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study" @default.
• Q33163524 prefLabel "Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study" @default.
• Q33163524 P1433 Q33163524-66CE867E-0327-4200-9CE0-DD1764796736 @default.
• Q33163524 P1476 Q33163524-566D9A51-B64D-4A1C-9981-70940192F31E @default.
• Q33163524 P2093 Q33163524-0F5847A0-ADAD-480A-8EF2-E5C5AE573F7E @default.
• Q33163524 P2093 Q33163524-17434C06-D77E-4334-AC0F-A8AE0452004D @default.
• Q33163524 P2093 Q33163524-60F421C1-93A5-4455-8A47-74369527DBA8 @default.
• Q33163524 P2093 Q33163524-B2ADD0C0-F4F9-40A7-B26B-D3C190F108F2 @default.
• Q33163524 P2093 Q33163524-D4BF9E11-C3D3-425D-AD00-2375F168E8C3 @default.
• Q33163524 P2093 Q33163524-DC4FE758-26B3-4325-9E64-5420A7E86035 @default.
• Q33163524 P2860 Q33163524-05DD7FD7-4C00-4451-98C8-B235CB90E3DB @default.
• Q33163524 P2860 Q33163524-137CC0CE-D432-4428-A0A7-C7C3D48F2A8E @default.
• Q33163524 P2860 Q33163524-21BD4E70-B6B4-44B7-B0BB-777173974C84 @default.
• Q33163524 P2860 Q33163524-2A6FC0BC-ED38-48BE-BDC6-5993FDE74BFC @default.
• Q33163524 P2860 Q33163524-2F4D76AB-B36D-4632-9929-42272EEF6812 @default.
• Q33163524 P2860 Q33163524-52AC481D-250F-4121-8CF5-0501B8315A60 @default.
• Q33163524 P2860 Q33163524-5AEA9584-3648-42FA-818F-920A2663C1BE @default.
• Q33163524 P2860 Q33163524-5B6039B1-8E20-4676-9602-A641D6AEBFB8 @default.
• Q33163524 P2860 Q33163524-6FEAF67B-1999-4542-B22F-D28D7CCA9895 @default.
• Q33163524 P2860 Q33163524-875C4904-989D-4F63-B362-1A55B30B85B0 @default.
• Q33163524 P2860 Q33163524-94885F39-DED3-4719-BB09-8F43E4FA3487 @default.
• Q33163524 P2860 Q33163524-9BA23F37-FF5B-41CB-8F87-D313F05C05CD @default.
• Q33163524 P2860 Q33163524-AC72F52D-4E29-43E7-9BA1-81ED0E357932 @default.
• Q33163524 P2860 Q33163524-B94AEEDB-AF10-44E9-982D-B03E3E2CD314 @default.
• Q33163524 P2860 Q33163524-CA3B3B35-6CFE-4C7E-8FF9-0C6C8F846FE5 @default.
• Q33163524 P2860 Q33163524-CDDB5384-F026-40CA-8807-CA93243193D4 @default.
• Q33163524 P2860 Q33163524-DE0230D8-C631-4027-A7AD-7BBBE6E67357 @default.
• Q33163524 P2860 Q33163524-EBA4A71C-E255-4DB1-BD5F-4071DC20FB72 @default.
• Q33163524 P2860 Q33163524-F573BF4D-9AE8-481E-B998-F9E9DE2BB0BE @default.
• Q33163524 P2860 Q33163524-F70C9E0C-7E5C-4A14-A838-56695B0505A0 @default.
• Q33163524 P2860 Q33163524-F800529A-150C-4BE1-A05F-8ECB590B0BFE @default.
• Q33163524 P304 Q33163524-FE89FBDB-8845-4BA8-8BDF-BBE3FE733FEF @default.
• Q33163524 P31 Q33163524-34026856-A93F-4E82-8225-D7FA3C952ED2 @default.
• Q33163524 P356 Q33163524-831A65E6-E2F6-4614-B119-9CADBAC8FE80 @default.

• next